Dare Bioscience Files 8-K on Financials
Ticker: DARE · Form: 8-K · Filed: May 14, 2024 · CIK: 1401914
Sentiment: neutral
Topics: financial-condition, operations, filing
TL;DR
Dare Bioscience filed an 8-K on May 14, 2024, updating investors on their financial condition and operations.
AI Summary
On May 14, 2024, Dare Bioscience, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Dare Bioscience's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting financial condition and results of operations, without indicating any immediate material adverse events.
Key Players & Entities
- Dare Bioscience, Inc. (company) — Registrant
- May 14, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36395 (identifier) — Commission File Number
- 20-4139823 (identifier) — I.R.S. Employer Identification No.
- 3655 Nobel Drive, Suite 260, San Diego, CA 92122 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by Dare Bioscience, Inc.?
The primary purpose of this 8-K filing is to report on the company's Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on May 14, 2024.
In which state is Dare Bioscience, Inc. incorporated?
Dare Bioscience, Inc. is incorporated in Delaware.
What is the Commission File Number for Dare Bioscience, Inc.?
The Commission File Number for Dare Bioscience, Inc. is 001-36395.
What is the business address of Dare Bioscience, Inc.?
The business address of Dare Bioscience, Inc. is 3655 Nobel Drive, Suite 260, San Diego, CA 92122.
Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-05-14 08:05:24
Filing Documents
- form8-k.htm (8-K) — 35KB
- ex99-1.htm (EX-99.1) — 59KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-019087.txt ( ) — 282KB
- dare-20240514.xsd (EX-101.SCH) — 3KB
- dare-20240514_lab.xml (EX-101.LAB) — 33KB
- dare-20240514_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DAR BIOSCIENCE, INC. Dated: May 14, 2024 By: /s/ Sabrina Martucci Johnson Name: Sabrina Martucci Johnson Title: President and Chief Executive Officer -3-